Publications by authors named "Barbara A Sullivan"

Claim this Profile
P
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques.
Alexander Kistner, Jessica A Chichester, Lili Wang, Roberto Calcedo, Jenny A Greig, Barbara A Sullivan

Gene Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study.
Lubna Abuqayyas, Laurence E Cheng, Marcia Teixeira Dos Santos, Barbara A Sullivan, Norma Ruiz-Santiago

ACR Open Rheumatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression.
Lili Wang, Claude C Warzecha, Alexander Kistner, Jessica A Chichester, Peter Bell, Barbara A Sullivan

Mol Ther Methods Clin Dev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target.
Mark A Kroenke, Troy E Barger, Jenny Hu, Mieke Jill Miller, Kevin Kalenian, Barbara A Sullivan

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study.
Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Barbara A Sullivan

Intest Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, Brian G Feagan, Edward V Loftus, Barbara A Sullivan

Gastroenterology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
Laurence E Cheng, Zahir Amoura, Benjamin Cheah, Falk Hiepe, Barbara A Sullivan

Arthritis Rheumatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis.
Michael J Boedigheimer, David A Martin, Zahir Amoura, Jorge Sánchez-Guerrero, Juanita Romero-Diaz, Barbara A Sullivan

Lupus Sci Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus.
Victoria P Werth, David Fiorentino, Barbara A Sullivan, Michael J Boedigheimer, Kit Chiu

Arthritis Rheumatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases.
Wei-Jian Pan, Kathleen Köck, William A Rees, Barbara A Sullivan, Christine M Evangelista

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection.
Isaac Engel, Kirsten Hammond, Barbara A Sullivan, Xi He, Ichiro Taniuchi

J Exp Med· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity.
Vincent Lombardi, Philippe Stock, Abinav K Singh, Jerome Kerzerho, Wen Yang, Barbara A Sullivan

J Immunol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
Barbara A Sullivan, Niranjana A Nagarajan, Gerhard Wingender, Jing Wang, Iain Scott

J Immunol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid test: lipid antigens get into the groove.
Mitchell Kronenberg, Barbara A Sullivan

Immunity· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of pre- and postselection TCRalphabeta+ intraepithelial lymphocyte precursors in the thymus.
Denise Gangadharan, Florence Lambolez, Antoine Attinger, Yiran Wang-Zhu, Barbara A Sullivan

Immunity· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
Yang Liu, Randal D Goff, Dapeng Zhou, Jochen Mattner, Barbara A Sullivan

J Immunol Methods· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Gerhard Wingender, Martina Berg, Frank Jüngerkes, Linda Diehl, Barbara A Sullivan

Eur J Immunol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
Douglass Wu, Dirk M Zajonc, Masakazu Fujio, Barbara A Sullivan, Yuki Kinjo

Proc Natl Acad Sci U S A· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.
Barbara A Sullivan, Mitchell Kronenberg

J Clin Invest· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An MHC class Ib-restricted TCR that cross-reacts with an MHC class Ia molecule.
Lisa M Reed-Loisel, Barbara A Sullivan, Oskar Laur, Peter E Jensen

J Immunol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD1 and MHC II find different means to the same end.
Barbara A Sullivan, Niranjana A Nagarajan, Mitchell Kronenberg

Trends Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
Tomomi Kuwana, Lisa Bouchier-Hayes, Jerry E Chipuk, Christine Bonzon, Barbara A Sullivan

Mol Cell· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.
Peter E Jensen, Barbara A Sullivan, Lisa M Reed-Loisel, Dominique A Weber

Immunol Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homeostatic proliferation of a Qa-1b-restricted T cell: a distinction between the ligands required for positive selection and for proliferation in lymphopenic hosts.
Barbara A Sullivan, Lisa M Reed-Loisel, Gilbert J Kersh, Peter E Jensen

J Immunol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
LiQi Li, Barbara A Sullivan, Carla J Aldrich, Mark J Soloski, James Forman

J Immunol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis